Stay updated on DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. It appears to involve minor template and layout adjustments without changes to study data.
    Difference
    0.1%
    Check dated 2026-04-16T10:00:42.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:08:32.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision metadata updated: added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T17:00:17.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Added Fallopian Tube Cancer to the Conditions section and added Genetic and Rare Diseases Information Center to the Resources.
    Difference
    0.2%
    Check dated 2026-02-18T03:43:50.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page shows a minor site maintenance update: a new Revision: v3.4.2 was added and older notices (including the funding lapse notice and Revision: v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T01:46:38.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Added a government funding status notice indicating potential delays and open NIH facilities; updated the page revision to v3.4.1, replacing the previous v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-03T22:33:04.000Z thumbnail image

Stay in the know with updates to DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial page.